Real-time enrollment status for this beta-thalassemia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:35 AM UTC
| NCT Number | NCT06271512 |
| Recruiting Status | Recruiting |
| Condition | Beta-Thalassemia |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Genetix Biotherapeutics Inc. |
| Last Updated on CT.gov | February 11, 2025 (Feb 11, 2025) |
As of July 13, 2026: Clinical trial NCT06271512 is currently recruiting participants. This clinical trial study for beta-thalassemia is actively seeking new participants at 6 locations across the United States. The study is sponsored by Genetix Biotherapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06271512 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06271512 was last updated Feb 11, 2025 (February 11, 2025). HelloStudys verifies this status automatically.